The proportion of CD4+FOXP3+ cells among the CD4+ population was significantly lower in the BM of RA in comparison with OA patients (Figure 2a,b), although the level of FOXP3 expression per cell in both patient groups was similar. The gene discussed is FOXP3; the disease is rheumatoid arthritis.